ID

40841

Descrizione

Efficacy of Losartan + Amlodipine Compared to Amlodipine Alone in the Treatment of Uncontrolled High Blood Pressure (MK-0954F-399); ODM derived from: https://clinicaltrials.gov/show/NCT01277822

collegamento

https://clinicaltrials.gov/show/NCT01277822

Keywords

versioni (1)
  1. 23/05/20 23/05/20 -
Titolare del copyright

See clinicaltrials.gov

Caricato su

23 maggio 2020

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Hypertension NCT01277822

Inglese

Eligibility Hypertension NCT01277822

1 moduli  
Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
participants with essential hypertension:
Descrizione

Essential Hypertension

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0085580
who are on single drug therapy
Descrizione

Pharmacotherapy Drug Single

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0013216
UMLS CUI [1,2]
C0013227
UMLS CUI [1,3]
C0205171
who are newly diagnosed and not yet taking any drug therapy, or have not had any drug therapy for at least 2 weeks prior to entering study
Descrizione

Newly Diagnosed | Pharmacotherapy Absent

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1518321
UMLS CUI [2,1]
C0013216
UMLS CUI [2,2]
C0332197
who have blood pressure readings of 90mmhg ≤ msdbp < 110mmhg and 140mmhg ≤ mssbp <180mmhg after 2 weeks wash-out for patients on single agent.
Descrizione

Sitting diastolic blood pressure mean | Sitting systolic blood pressure mean | Status post Washout Period

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1319894
UMLS CUI [1,2]
C0444504
UMLS CUI [2,1]
C1319893
UMLS CUI [2,2]
C0444504
UMLS CUI [3,1]
C0231290
UMLS CUI [3,2]
C1710661
randomization (visit 3)
Descrizione

Randomization

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0034656
after dosing of amlodipine 5mg for 6 weeks, blood pressure readings are:
Descrizione

Status post Amlodipine Unit dose | Blood pressure determination

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0231290
UMLS CUI [1,2]
C0051696
UMLS CUI [1,3]
C0869039
UMLS CUI [2]
C0005824
90mmhg ≤ msdbp < 110mmhg and 140mmhg ≤ mssbp < 180mmhg.
Descrizione

Sitting diastolic blood pressure mean | Sitting systolic blood pressure mean

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1319894
UMLS CUI [1,2]
C0444504
UMLS CUI [2,1]
C1319893
UMLS CUI [2,2]
C0444504
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
participant with msdbp ≥ 110mmhg or mssbp ≥ 180mmhg.
Descrizione

Sitting diastolic blood pressure mean | Sitting systolic blood pressure mean

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1319894
UMLS CUI [1,2]
C0444504
UMLS CUI [2,1]
C1319893
UMLS CUI [2,2]
C0444504
participant currently taking ≥ 2 antihypertensive medications (note: fixed-dose combination medicine should be counted as the number of active ingredients).
Descrizione

Antihypertensive Agents Quantity

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0003364
UMLS CUI [1,2]
C1265611
participant with known secondary hypertension of any etiology.
Descrizione

Secondary hypertension | Etiology Any

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0155616
UMLS CUI [2,1]
C0015127
UMLS CUI [2,2]
C1552551
participant with malignant hypertension or current evidence of impending or active malignant hypertension, including headache, papilledema, cardiac ischemia, or pulmonary congestion precipitated by elevated blood pressure.
Descrizione

Malignant Hypertension | Malignant Hypertension Impending | Headache | Papilledema | Myocardial Ischemia | Pulmonary congestion Precipitated by Elevated blood pressure

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0020540
UMLS CUI [2,1]
C0020540
UMLS CUI [2,2]
C0332190
UMLS CUI [3]
C0018681
UMLS CUI [4]
C0030353
UMLS CUI [5]
C0151744
UMLS CUI [6,1]
C0242073
UMLS CUI [6,2]
C1444748
UMLS CUI [6,3]
C0497247
participant with known intolerance, contraindication or hypersensitivity to any component of dihydropyridines, angiotensin ii receptor blockers.
Descrizione

Intolerance to Component Dihydropyridines | Medical contraindication Component Dihydropyridines | Hypersensitivity Component Dihydropyridines | Intolerance to Component Angiotensin II receptor antagonist | Medical contraindication Component Angiotensin II receptor antagonist | Hypersensitivity Component Angiotensin II receptor antagonist

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1744706
UMLS CUI [1,2]
C1705248
UMLS CUI [1,3]
C0012315
UMLS CUI [2,1]
C1301624
UMLS CUI [2,2]
C1705248
UMLS CUI [2,3]
C0012315
UMLS CUI [3,1]
C0020517
UMLS CUI [3,2]
C1705248
UMLS CUI [3,3]
C0012315
UMLS CUI [4,1]
C1744706
UMLS CUI [4,2]
C1705248
UMLS CUI [4,3]
C0521942
UMLS CUI [5,1]
C1301624
UMLS CUI [5,2]
C1705248
UMLS CUI [5,3]
C0521942
UMLS CUI [6,1]
C0020517
UMLS CUI [6,2]
C1705248
UMLS CUI [6,3]
C0521942
participant showing positive in pregnancy test, lactating woman, or woman who intends to get pregnant during the study period.
Descrizione

Pregnancy test positive | Breast Feeding | Pregnancy, Planned

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0240802
UMLS CUI [2]
C0006147
UMLS CUI [3]
C0032992
Ritorna all'inizio della pagina

Similar models

Eligibility Hypertension NCT01277822

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
Essential Hypertension
Item
participants with essential hypertension:
boolean
C0085580 (UMLS CUI [1])
Pharmacotherapy Drug Single
Item
who are on single drug therapy
boolean
C0013216 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
C0205171 (UMLS CUI [1,3])
Newly Diagnosed | Pharmacotherapy Absent
Item
who are newly diagnosed and not yet taking any drug therapy, or have not had any drug therapy for at least 2 weeks prior to entering study
boolean
C1518321 (UMLS CUI [1])
C0013216 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Sitting diastolic blood pressure mean | Sitting systolic blood pressure mean | Status post Washout Period
Item
who have blood pressure readings of 90mmhg ≤ msdbp < 110mmhg and 140mmhg ≤ mssbp <180mmhg after 2 weeks wash-out for patients on single agent.
boolean
C1319894 (UMLS CUI [1,1])
C0444504 (UMLS CUI [1,2])
C1319893 (UMLS CUI [2,1])
C0444504 (UMLS CUI [2,2])
C0231290 (UMLS CUI [3,1])
C1710661 (UMLS CUI [3,2])
Randomization
Item
randomization (visit 3)
boolean
C0034656 (UMLS CUI [1])
Status post Amlodipine Unit dose | Blood pressure determination
Item
after dosing of amlodipine 5mg for 6 weeks, blood pressure readings are:
boolean
C0231290 (UMLS CUI [1,1])
C0051696 (UMLS CUI [1,2])
C0869039 (UMLS CUI [1,3])
C0005824 (UMLS CUI [2])
Sitting diastolic blood pressure mean | Sitting systolic blood pressure mean
Item
90mmhg ≤ msdbp < 110mmhg and 140mmhg ≤ mssbp < 180mmhg.
boolean
C1319894 (UMLS CUI [1,1])
C0444504 (UMLS CUI [1,2])
C1319893 (UMLS CUI [2,1])
C0444504 (UMLS CUI [2,2])
Item Group
C0680251 (UMLS CUI)
Sitting diastolic blood pressure mean | Sitting systolic blood pressure mean
Item
participant with msdbp ≥ 110mmhg or mssbp ≥ 180mmhg.
boolean
C1319894 (UMLS CUI [1,1])
C0444504 (UMLS CUI [1,2])
C1319893 (UMLS CUI [2,1])
C0444504 (UMLS CUI [2,2])
Antihypertensive Agents Quantity
Item
participant currently taking ≥ 2 antihypertensive medications (note: fixed-dose combination medicine should be counted as the number of active ingredients).
boolean
C0003364 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
Secondary hypertension | Etiology Any
Item
participant with known secondary hypertension of any etiology.
boolean
C0155616 (UMLS CUI [1])
C0015127 (UMLS CUI [2,1])
C1552551 (UMLS CUI [2,2])
Malignant Hypertension | Malignant Hypertension Impending | Headache | Papilledema | Myocardial Ischemia | Pulmonary congestion Precipitated by Elevated blood pressure
Item
participant with malignant hypertension or current evidence of impending or active malignant hypertension, including headache, papilledema, cardiac ischemia, or pulmonary congestion precipitated by elevated blood pressure.
boolean
C0020540 (UMLS CUI [1])
C0020540 (UMLS CUI [2,1])
C0332190 (UMLS CUI [2,2])
C0018681 (UMLS CUI [3])
C0030353 (UMLS CUI [4])
C0151744 (UMLS CUI [5])
C0242073 (UMLS CUI [6,1])
C1444748 (UMLS CUI [6,2])
C0497247 (UMLS CUI [6,3])
Intolerance to Component Dihydropyridines | Medical contraindication Component Dihydropyridines | Hypersensitivity Component Dihydropyridines | Intolerance to Component Angiotensin II receptor antagonist | Medical contraindication Component Angiotensin II receptor antagonist | Hypersensitivity Component Angiotensin II receptor antagonist
Item
participant with known intolerance, contraindication or hypersensitivity to any component of dihydropyridines, angiotensin ii receptor blockers.
boolean
C1744706 (UMLS CUI [1,1])
C1705248 (UMLS CUI [1,2])
C0012315 (UMLS CUI [1,3])
C1301624 (UMLS CUI [2,1])
C1705248 (UMLS CUI [2,2])
C0012315 (UMLS CUI [2,3])
C0020517 (UMLS CUI [3,1])
C1705248 (UMLS CUI [3,2])
C0012315 (UMLS CUI [3,3])
C1744706 (UMLS CUI [4,1])
C1705248 (UMLS CUI [4,2])
C0521942 (UMLS CUI [4,3])
C1301624 (UMLS CUI [5,1])
C1705248 (UMLS CUI [5,2])
C0521942 (UMLS CUI [5,3])
C0020517 (UMLS CUI [6,1])
C1705248 (UMLS CUI [6,2])
C0521942 (UMLS CUI [6,3])
Pregnancy test positive | Breast Feeding | Pregnancy, Planned
Item
participant showing positive in pregnancy test, lactating woman, or woman who intends to get pregnant during the study period.
boolean
C0240802 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0032992 (UMLS CUI [3])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial